Covance
Home About Covance Investor Relations News Careers Contact Us
Home > Drug Development Services > Clinical > Pharmacometrics > Case Studies
 Advanced Search
Take me to...
Find a service
Drug Development Services
Nonclinical
Clinical
Commercialization
Industries We Serve
Biotech
Environmental
Food & Dietary Supplements
Pharma
Research
Vaccines
Antibody Products Store
Volunteer for a Study
Investigators
Information Library
Animal Welfare
Pharmacometrics
Case Studies
Results: Timely NDA Submission
In order to meet an aggressive NDA submission date, over 100,000 vital signs data points — from a Phase I pharmacodynamic study in 150 subjects — were entered, validated and queried. The subsequent 7,000-page fully integrated study report was issued 16 days after database lock, with Covance finalizing the report at the client's headquarters less than one week later.
Overview
Services
Case Studies
Systems & Technology
Contact